Reports: Saudi giant want to sign Algerian Ismaël Bennacer
Reports: Saudi giant want to sign Algerian Ismaël Bennacer
Algerian international Bennacer is on the radar of several Saudi clubs this summer, including Saudi giants Al Ittihad, who have been heavily linked with the Algerian international, who is currently in negotiations with Italian giants AC Milan for a possible departure in the current summer transfer window.
The player's contract expires in the summer of 2027 with AC Milan, but the instability of his role with the club and his loan spell last season at Olympique de Marseille has made him think long and hard about leaving the club and looking for another experience.
Repeated injuries and bad luck
The Algerian international was certainly hoping to get a permanent role in the Italian giants' squad, but he was unlucky with injuries, which made the technical management of the team think about not relying on him in the main, and the number of injuries made him participate in only 20 games between AC Milan and Marseille last season, which gave a lot of doubts about his future.
How much will Etihad pay for this deal
In a strategic move to facilitate the transfer, agent Ben Nasser is capitalizing on his longstanding relationship with former Al-Ittihad superstar Karim Benzema. The French-Algerian striker's influence could prove pivotal in negotiations as AC Milan push to secure the Algerian international's signature.
Sources close to Al-Sharq Al-Awsat reveal that discussions between the Rossoneri and Al-Ittihad are progressing steadily, with both clubs working to finalize terms. The deal, if completed, would mark a significant coup for the Serie A giants as they look to bolster their squad with top-tier talent.
The involvement of a high-profile figure like Benzema adds an intriguing layer to the negotiations, highlighting the interconnected nature of modern football's transfer market. All eyes now turn to Milan as they attempt to conclude what could be one of the summer's most talked-about moves.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Roma interested in Devis Vasquez as second-choice keeper
Roma are also making moves on the goalkeeping front. According to Gianluca Di Marzio, the Giallorossi have inquired about Devis Vasquez who has recently become a free agent following his unsuccessful spell at AC Milan. Born in 1998, Vasquez arrived at AC Milan in January 2023 from Paraguayan club Guaraní, but never managed to find a place in the first team. After a loan spell at Sheffield Wednesday and two mixed seasons at Ascoli and Empoli, the goalkeeper is now in Roma's sights, which is evaluating him as a possible free transfer alternative while waiting to finalize Gollini's future. No negotiations have been made at this time, but contacts have been initiated.
Yahoo
23 minutes ago
- Yahoo
Atalanta eye move for Everton striker Beto
Everton striker Beto is a target for Serie A side Atalanta as they look to bolster their attack ahead of next season, per La Gazzetta dello Sport (via Tuttomercatoweb). The 2023/24 Europa League champions are in the market for a striker after losing Mateo Retegui to Saudi Pro League side Al-Qadsiah. Ademola Lookman could also leave this summer for Atletico Madrid or Inter Milan. Atalanta have turned to the Everton centre-forward, who knows Serie A well from his time with Udinese, where he scored 22 times in 65 appearances. The Toffees picked Beto up from the Italian side. Everton already spent £27 million to sign Thierno Barry from Villarreal and might consider letting Beto leave. The manager might not welcome the idea after seeing Armando Broja and Dominic Calvert-Lewin leave. The Toffees are light in front, and sanctioning Beto's exit might not be wise. Beto bagged eight goals and two assists in 30 Premier League appearances last term. Everton should hold on to Beto unless Atalanta can cough up serious money (View). He is far from the most prolific striker. However, he remains a wise squad option, especially under David Moyes. His size, work rate, and willingness to press make him an ideal back-up to Barry, who will need time to adapt to the Premier League. With Calvert-Lewin and Broja gone, Everton cannot afford to weaken their frontline further. Beto knows his role and fits Moyes' physical, direct system. His hold-up play, aerial ability, and link-up strengths remain underrated. Atalanta might be tempted by his Serie A experience, but unless they are offering enough to fund a clear upgrade, Everton should resist. Moyes needs depth and reliability, not another hole to patch. Beto, who earns £50,000 per week, is the right man to keep around, unless the money is too good to refuse.
Business Wire
25 minutes ago
- Business Wire
Advicenne Receives Marketing Authorization and Reimbursement for Sibnayal® in Saudi Arabia
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth® - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, obtains marketing authorization (MA) and reimbursement status for Sibnayal® (a fixed combination of potassium citrate and potassium bicarbonate) in the Kingdom of Saudi Arabia (KSA). Marketing authorization for Sibnayal® (ADV7103) in distal Renal Tubular Acidosis (dRTA) in KSA has been granted, based on the European registration dossier. Furthermore, Saudi authorities have agreed a reimbursement rate in line with the best European pricing. This achievment results of a close collaboration between Advicenne and its local partner, Taïba Healthcare, a leading distributor of pharmaceutical products in the Gulf region. Advicenne will act as the marketing authorization holder, while Taïba Healthcare will manage local marketing activities. The incidence of dRTA is higher in Gulf countries than in Europe or the United States, and prevalence in KSA could be estimated around 600 to 800 patients. Sibnayal® is already prescribed through early access programs in several Gulf countries outside Saudi Arabia. This milestone paves the way for registrations in GCC countries where the application is filed. Didier Laurens, CEO of Advicenne, declared: 'I am particularly proud of this important achievement and wish to congratulate both Advicenne and Taïba Healthcare teams, whose efforts were instrumental in informing and convincing the Saudi health authorities. The reimbursement obtained, comparable to the highest levels recorded in Europe, further attests to the significant therapeutic value of Sibnayal® in a region with one of the highest prevalence rates of dRTA worldwide.' About Advicenne Advicenne (Euronext: ALDVI) is a specialty pharmaceutical company founded in 2007, specializing in the development of innovative treatments in Nephrology. Its lead product Sibnayal® (ADV7103) has received its Marketing Approval for distal renal tubular acidosis in EU and GB. ADV7103 is currently in late-stage development in cystinuria in Europe and in dRTA and cystinuria in the US and in Canada. Headquartered in Paris, Advicenne, listed on the Euronext Paris stock exchange since 2017, has now been listed on Euronext Growth Paris since its transfer on March 30, 2022. For additional information, see: Disclaimer This press release contains certain forward-looking statements concerning Advicenne group and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Advicenne considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the 2024 Universal Registration Document filed with the French financial market authority on April 29, 2025 (a copy of which is available on and to the development of economic conditions, financial markets and the markets in which Advicenne operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Advicenne or not currently considered material by Advicenne. The occurrence of all or part of such risks could cause actual results, financial conditions, performance, or achievements of Advicenne to be materially different from such forward-looking statements. Advicenne expressly declines any obligation to update such forward-looking statements.
